Astra Zeneca

AstraZeneca, a UK-based pharmaceutical manufacturer, has set ambitious climate targets. The company aims for net-zero greenhouse gas emissions across its value chain by FY2045, with science-based targets validated by the SBTi.

Emissions Breakdown:

• In 2025, AstraZeneca reported Scope 1 emissions of approximately 62.59 million kg CO2e.
• In 2024, Scope 1 emissions were approximately 125.39 million kg CO2e.
• In 2023, Scope 1 emissions stood at approximately 180.90 million kg CO2e.
• In 2022, AstraZeneca's Scope 1 emissions were around 237.70 million kg CO2e, and Scope 2 (market-based) emissions were about 18.49 million kg CO2e.
• For 2021, the company reported Scope 1 emissions of approximately 239.47 million kg CO2e, Scope 2 (market-based) emissions of about 21.14 million kg CO2e, and Scope 3 emissions of approximately 5.93 billion kg CO2e. Key Scope 3 categories included purchased goods and services (approximately 4.40 billion kg CO2e) and use of sold products (approximately 835.34 million kg CO2e).
• In 2020, Scope 1 emissions were about 239.46 million kg CO2e, Scope 2 (market-based) emissions were around 32.22 million kg CO2e, and Scope 3 emissions totalled approximately 5.69 billion kg CO2e.

Reduction Targets:

AstraZeneca has committed to several significant reductions:

• Near-term (by 2026): A 98% absolute reduction in Scope 1 and 2 GHG emissions from a 2015 baseline.
• Near-term (by 2030): A 50% absolute reduction in Scope 3 GHG emissions from a 2019 baseline. This includes specific targets such as an 80% reduction in Scope 3 emissions from fuel and energy related activities, upstream leased assets, and downstream leased assets, and a 95% reduction from the use of sold products.
• Long-term (by 2045): A 90% absolute reduction in Scope 3 GHG emissions from a 2019 base year, aligning with its net-zero commitment.

The company also aims for 100% renewable electricity consumption globally by 2025 and a 100% electric road fleet by the end of 2025. Furthermore, AstraZeneca commits that 95% of its suppliers by spend (covering purchased goods and services and capital goods) and 50% of its suppliers by spend (covering upstream transportation and distribution and business travel) will have science-based targets by FY2025.